Immunoprecise Antibodies (OTCMKTS:IPATF) Trading Up 2.4%

Immunoprecise Antibodies Ltd (OTCMKTS:IPATF)’s share price was up 2.4% on Thursday . The stock traded as high as $0.37 and last traded at $0.37, approximately 11,622 shares changed hands during mid-day trading. A decline of 41% from the average daily volume of 19,539 shares. The stock had previously closed at $0.36.

The firm has a 50-day moving average of $0.41 and a two-hundred day moving average of $0.49.

About Immunoprecise Antibodies (OTCMKTS:IPATF)

ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services.

Featured Article: Understanding debt-to-equity ratio in fundamental analysis

Receive News & Ratings for Immunoprecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immunoprecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.